tirzepatide greenwood in Long-Term Demonstrates Benefits Patients With CKD, Obesity, and HFpEF Compounded Tirzepatide (GLP-1/GIP)

Swap based on your taste preference or protein goals

Its physiological actions include stimulating glucose-dependent insulin secretion from pancreatic beta cells, suppressing glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways

Combined, the full Replenza system costs approximately $74.96 per month at regular pricing, or less with subscription discounts

Evidence snapshot: The strongest available evidence is a small Phase 1 human trial (Teichman et al., 2006) showing dose-dependent, sustained elevation of GH and IGF-1 in healthy adults

Can a patient who has had a thyroidectomy (nonmedullary) and a nephrectomy safely use a GLP1 receptor agonist?